Open House - Global Healthcare 2022: Renaissance BioScience | Edison Group
Renaissance BioScience is an Environmental Impact company whose bioengineering platform technologies develop innovative, market-ready, functional microorganisms that provide solutions to a broad range of health and environmental problems.
-
Dr. John Husnik, CSO and Office of the CEO, Renaissance BioScience
Dr. John Husnik is a leading researcher in the area of yeast strain development techniques, as well as having significant experience developing and applying novel and innovative yeast-based solutions to multiple food and beverage industry problems. John and his team advanced and commercialized the H2S-preventing yeast traits, originally discovered and patented by Dr. Linda Bisson at the University of California, Davis, for the global wine and beer industries. In addition, John and his team discovered, patented and commercialized the acrylamide-reducing yeast technology owned by Renaissance BioScience Corp for the global food industry. John and team are also responsible for the RNA project from idea stage to todays' patent-pending status. Dr. Husnik earned his Bachelor degree in Microbiology and his Masters degree in Food Science from the University of Guelph, and holds a Ph.D. in Genetics from the University of British Columbia.
